Daniel A. Colón-Ríos

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Direct targeting of amplified gene loci for proapoptotic anticancer therapy”.

Direct targeting of amplified gene loci for proapoptotic anticancer therapy

Nature Biotechnology(2021)10.1038/s41587-021-01057-5

N/A

0DataRank · unranked

33 citations

Daniel A. Colón-Ríos, Hemanta C. Rao Tumu, Yanfeng Liu, Elias Quijano, A. Krysztofiak +7 more

Vulnerability of IDH1-Mutant Cancers to Histone Deacetylase Inhibition via Orthogonal Suppression of DNA Repair

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-21-0456

N/A

0DataRank · unranked

18 citations

A. Krysztofiak, Yanfeng Liu, Daniel A. Colón-Ríos, Faye A. Rogers, Peter M. Glazer +1 more

Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition

Oncotarget(2024)10.18632/oncotarget.28651

N/A

0DataRank · unranked

8 citations

Elias Quijano, Zaira Ianniello, Daniel A. Colón-Ríos, A. Krysztofiak, Rashed Abdullah +7 more

Harnessing exDNA for precision exatecan delivery in cancer: a novel antibody-drug conjugate approach

Molecular Cancer(2025)10.1186/s12943-025-02462-z

N/A

0DataRank · unranked

3 citations

Huimei Lu, Elias Quijano, Daniel A. Colón-Ríos, Madison Rackear, Venu Bommireddy +4 more

PARP inhibitor resistance in IDH1-mutant cancers due to loss of end protection factors, 53BP1 and REV7

NAR Cancer(2025)10.1093/narcan/zcaf047

N/A

0DataRank · unranked

1 citations

Jonathan Dow, A. Krysztofiak, Yanfeng Liu, Faye A. Rogers, Peter M. Glazer +1 more